Literature DB >> 9617571

PGE2 inhibits IL-2 and IL-4-dependent proliferation of CTLL-2 and HT2 cells.

T Gurlo1, W W Huang, H von Grafenstein.   

Abstract

The cytotoxic T cell line CTLL-2 and the T helper cell line HT2 proliferate in response to interleukin 2 (IL-2) or IL-4 without requiring stimulation by antigen through the T cell receptor and therefore lend themselves for studies of IL-2- and IL-4-dependent proliferation and signalling through their cognate receptors. Here we have used CTLL-2 and HT2 cells to investigate the effect of the inflammatory mediator prostaglandin E2 (PGE2) on IL-2- and IL-4-dependent proliferation. PGE2 inhibited IL-2- as well as IL-4-dependent proliferation of both CTLL-2 and HT2 cells, with IL-4-dependent proliferation being more sensitive than IL-2-dependent proliferation and CTLL-2 cells being more sensitive than HT2 cells. A quantitative dose-effect analysis revealed a two-step increase of inhibition (around 10(-10) M and 10(-5) M PGE2) for all combinations of cells and cytokines approaching 100% at high concentrations of PGE2. The data suggest that even in cases where synthesis of IL-2 and IL-4 is differentially affected by PGE2, IL-2- and IL-4-dependent T cells may still be similarly sensitive to PGE2 by way of their cytokine responsiveness. Furthermore, the effects of PGE2 may be mediated by more than one functional binding site or receptor subtype. PGE2 levels are an important consideration when CTLL-2 and HT2 cells are used for the measurement of IL-4 and IL-2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9617571     DOI: 10.1006/cyto.1997.0288

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  5 in total

1.  Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction.

Authors:  M Ueta; M-N Kweon; Y Sano; C Sotozono; J Yamada; N Koizumi; H Kiyono; S Kinoshita
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

2.  Immunologic changes to autologous transfusion after operational trauma in malignant tumor patients: neopterin and interleukin-2.

Authors:  Min Yan; Gang Chen; Ling-ling Fang; Zi-ming Liu; Xiu-lai Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2005-01       Impact factor: 3.066

3.  Lipoteichoic acid inhibits interleukin-2 (IL-2) function by direct binding to IL-2.

Authors:  L M Plitnick; R A Jordan; J A Banas; D M Jelley-Gibbs; M C Walsh; M T Preissler; E J Gosselin
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

4.  Prostaglandin E2 mediates growth arrest in NFS-60 cells by down-regulating interleukin-6 receptor expression.

Authors:  Kumudika I de Silva; Asif N Daud; JiangPing Deng; Stephen B Jones; Richard L Gamelli; Ravi Shankar
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

5.  Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells.

Authors:  N Kvirkvelia; I Vojnovic; T D Warner; V Athie-Morales; P Free; N Rayment; B M Chain; T W Rademacher; T Lund; I M Roitt; P J Delves
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.